Supernus Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 2,087 | 0.0% | 41,984 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,499 | 0.0% | 31,361 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 2,165 | 0.0% | 68,675 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 2,628 | 0.0% | 80,253 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,131 | 0.0% | 31,290 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 626 | 0.0% | 20,074 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 332 | 0.0% | 12,402 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 217 | 0.0% | 6,365 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 470 | 0.0% | 16,228 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,014 | 0.0% | 36,777 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,403 | 0.0% | 46,673 | 6/30/2023 |
| 2023 Q1 | 5/16/2023 | 1,650 | 0.0% | 45,536 | 3/31/2023 |
| 2022 Q3 | 11/14/2022 | 567 | 0.0% | 16,743 | 9/30/2022 |
| 2021 Q4 | 2/14/2022 | 823 | 0.0% | 28,220 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 501 | 0.0% | 18,768 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 333 | 0.0% | 10,801 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 1,246 | 0.0% | 47,608 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 998 | 0.0% | 39,678 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 274 | 0.0% | 13,139 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 685 | 0.0% | 28,854 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 304 | 0.0% | 16,883 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,194 | 0.0% | 50,330 | 12/31/2019 |
| 2014 Q1 | 5/14/2014 | 476 | 0.0% | 53,205 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 3,141 | 0.0% | 416,495 | 12/31/2013 |